Evidence map›Paper›PMID 32782447›Full record

ArticleDose-response : a publication of International Hormesis Society

Bactericidal Activity Study of ZrO

Ayodeji Precious Ayanwale, Alvaro de Jesús Ruíz-Baltazar, León Espinoza-Cristóbal, Simón Yobanny Reyes-López

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Dose-response : a publication of International Hormesis Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 38 citations in OpenAlex.

  1. BiogenicRSC advances · 2026
    Article
  2. Article
  3. AgChemical science · 2024
    Article
  4. Article
  5. AgPharmaceuticals (Basel, Switzerland) · 2022
    Review
  6. Alumina-Hydroxyapatite-Silver Spheres With Antibacterial Activity.Dose-response : a publication of International Hormesis Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ayodeji Precious AyanwaleInstituto de Ciencias Biomédicas, Universidad Autónoma de Ciudad Juárez, Envolvente del PRONAF y Estocolmo s/n, Ciudad Juárez, Chih, México.
Alvaro de Jesús Ruíz-BaltazarCONACYT-Centro de Física Aplicada y Tecnología Avanzada, Universidad Nacional Autónoma de México, Boulevard Juriquilla, Juriquilla Querétaro, QRO, México.
León Espinoza-CristóbalInstituto de Ciencias Biomédicas, Universidad Autónoma de Ciudad Juárez, Envolvente del PRONAF y Estocolmo s/n, Ciudad Juárez, Chih, México.
Simón Yobanny Reyes-LópezInstituto de Ciencias Biomédicas, Universidad Autónoma de Ciudad Juárez, Envolvente del PRONAF y Estocolmo s/n, Ciudad Juárez, Chih, México.ORCID https://orcid.org/0000-0002-9017-3233
Universidad Autónoma de Ciudad Juárez · MXUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In view of the continuous resistance to antibacterial agents by bacteria and the existing problems of silver nanoparticles as an antibacterial agent, this study reports on the synthesis of pure zirconium oxide, silver oxide, and ZrO

Indexed as

antibacterial activitiesmetal oxidesnanomaterialsol-gelZrO2-Ag2O nanoparticles

Identifiers

PMID32782447
PMCPMC7383718
OpenAlexW3044495987

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.